Impact of ABO-Incompatible Listing on Wait-List Outcomes Among Infants Listed for Heart Transplantation in the United States A Propensity Analysis

被引:50
作者
Almond, Christopher S. [1 ,3 ,4 ]
Gauvreau, Kimberlee [1 ,6 ]
Thiagarajan, Ravi R. [1 ,4 ]
Piercey, Gary E. [1 ]
Blume, Elizabeth D. [1 ,3 ,4 ]
Smoot, Leslie B. [1 ,3 ,4 ]
Fynn-Thompson, Francis [2 ,3 ,5 ]
Singh, Tajinder P. [1 ,3 ,4 ]
机构
[1] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA
[3] Childrens Hosp, Pediat Transplant Ctr, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
关键词
heart defects; congenital; heart failure; immunology; pediatrics; transplantation; CHILDREN; MORTALITY;
D O I
10.1161/CIRCULATIONAHA.109.885756
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The purported advantage of ABO-incompatible (ABO-I) listing is to reduce wait times and wait-list mortality among infants awaiting heart transplantation. We sought to describe recent trends in ABO-I listing for US infants and to determine the impact of ABO-I listing on wait times and wait-list mortality. Methods and Results-In this multicenter retrospective cohort study using Organ Procurement and Transplant Network data, infants <12 months of age listed for heart transplantation between 1999 and 2008 (n = 1331) were analyzed. Infants listed for an ABO-I transplant were compared with a propensity score-matched cohort listed for an ABO-compatible transplant through the use of a Cox shared-frailty model. The primary end point was time to heart transplantation. The percentage of eligible infants listed for an ABO-I heart increased from 0% before 2002 to 53% in 2007 (P < 0.001 for trend). Compared with infants listed exclusively for an ABO-compatible heart, infants with a primary ABO-I listing strategy (n = 235) were more likely to be listed 1A, to have congenital heart disease and renal failure, and to require extracorporeal membrane oxygenation. For the propensity score-matched groups (n = 197 matched pairs), there was no difference in wait-list mortality; however, infants with blood type O assigned an ABO-I listing strategy were more likely to undergo heart transplantation by 30 days (31% versus 16%; P = 0.007) with a less pronounced effect for infants with other blood types. Conclusions-The proportion of US infants listed for an ABO-I heart transplantation has risen dramatically in recent years but still appears to be preferentially used for sicker infant candidates. The ABO-I listing strategy is associated with a higher likelihood of transplantation within 30 days for infants with blood group O and may benefit a broader range of transplantation candidates. (Circulation. 2010;121:1926-1933.)
引用
收藏
页码:1926 / 1933
页数:8
相关论文
共 21 条
  • [1] Waiting List Mortality Among Children Listed for Heart Transplantation in the United States
    Almond, Christopher S. D.
    Thiagarajan, Ravi R.
    Piercey, Gary E.
    Gauvreau, Kimberlee
    Blume, Elizabeth D.
    Bastardi, Heather J.
    Fynn-Thompson, Francis
    Singh, T. P.
    [J]. CIRCULATION, 2009, 119 (05) : 717 - 727
  • [2] D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
  • [3] 2-B
  • [4] Blood type incompatible cardiac transplantation in young infants
    Daebritz, Sabine H.
    Schmoeckel, Michael
    Mair, Helmut
    Kozlik-Feldmann, Rainer
    Wittmann, Georg
    Kowalski, Christian
    Kaczmarek, Ingo
    Reichart, Bruno
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (03) : 339 - 343
  • [5] GRADY D, 2003, NY TIMES 0312
  • [6] Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy
    Holt, D. Byron
    Lublin, Douglas M.
    Phelan, Donna L.
    Boslaugh, Sarah E.
    Gandhi, Sanjiv K.
    Huddleston, Charles B.
    Saffitz, Jeffrey E.
    Canter, Charles E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (09) : 876 - 882
  • [7] Incidence and Risk Factors for Mortality in Infants Awaiting Heart Transplantation in the USA
    Mah, Douglas
    Singh, Tajinder P.
    Thiagarajan, Ravi R.
    Gauvreau, Kimberlee
    Piercey, Gary E.
    Blume, Elizabeth D.
    Fynn-Thompson, Francis
    Almond, Christopher S. D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (12) : 1292 - 1298
  • [8] McDiarmid S., 2007, SUMM ORG DON TRANSPL
  • [9] Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation
    Mital, S
    Addonizio, LJ
    Lamour, JM
    Hsu, DT
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (02) : 147 - 153
  • [10] Morrow WR, 1997, J HEART LUNG TRANSPL, V16, P1255